{
  "meta": {
    "title": "How_To_Approach_A_Case_Of_Iem_With_Glycogen_Storage_Disease",
    "url": "https://brainandscalpel.vercel.app/how-to-approach-a-case-of-iem-with-glycogen-storage-disease-e23f3998.html",
    "scrapedAt": "2025-11-29T18:33:01.977Z"
  },
  "questions": [
    {
      "id": 16443,
      "choices": [
        {
          "id": 65732,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphate dehydrogenase</span></span></span></p>"
        },
        {
          "id": 65733,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-Phosphatase</span></span></span></p>"
        },
        {
          "id": 65734,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate dehydrogenase complex (PDC)</span></span></span></p>"
        },
        {
          "id": 65735,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate kinase deficiency</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old girl is brought in by her mother due to failure to thrive and easy fatigability. Examination reveals severe anemia, splenomegaly, and jaundice. The patient&#39;s family history includes an unspecified &quot;blood problem.&quot; Hemoglobin electrophoresis is normal, and a complete blood count (CBC) shows normocytic anemia. Peripheral blood smear demonstrates numerous abnormal erythrocytes, including spiculated cells. Given these findings and the presence of an enzyme deficiency leading to anemia, what is the most common enzyme deficiency associated with this presentation?</span></span></span></p>",
      "unique_key": "Q3812556",
      "question_audio": null,
      "question_video": null,
      "map_id": 33053,
      "difficulty_level": "difficult",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Pyruvate kinase deficiency</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate kinase deficiency (PKD)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>erythrocyte enzymopathy </strong>involving the <strong>glycolytic pathway</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Erythrocytes </strong>have <strong>evolved without oxidative phosphorylation </strong>to form <strong>adenosine triphosphate </strong>(ATP), the compound essential for providing the erythrocyte energy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild form of PKD; May appear to have no symptoms at all.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe form of PKD Symptoms include:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chills Fatigue</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Earlier in life symptoms tend to be detected</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pallor, dark urine and enlarged spleen</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biochemical findings of hemolytic anemia;</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated indirect bilirubin levels</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced Haptoglobin</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated total reticulocyte count</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated serum LDH</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis of PKD</span></strong></span></span></p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Measuring the amount of pyruvate kinase in red blood cells</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If there is a family history, mutation analysis could be done to determine carrier status of an individual</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical care and Treatment</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the severe cases</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">multiple blood transfusions may be required</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenectomy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glucose-6-phosphate dehydrogenase deficiency </strong>will results in <strong>anemia </strong>with <strong>Smear findings of `Bite cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glucose-6-Phosphatase deficiency </strong>will results in the <strong>Type 1 Glycogen storage disorder</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pyruvate dehydrogenase complex </strong>(PDC) deficiency will results in the <strong>Lactic acidosis</strong>, <strong>ataxia </strong>and <strong>retardation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate kinase deficiency </strong>is an <strong>enzyme disorder </strong>that <strong>leads to hemolytic anemia </strong>by affecting the <strong>glycolytic pathway in red blood cells</strong>, resulting in <strong>insufficient ATP production </strong>and <strong>decreased cell survival</strong>. The clinical presentation can include <strong>failure to thrive, severe anemia</strong>, <strong>splenomegaly, </strong>and <strong>jaundice</strong>. The presence of <strong>bizarre erythrocytes</strong>, including <strong>spiculated cells on the peripheral smear</strong>, is <strong>consistent with hemolytic anemia</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Nelson 21<sup>st</sup> edition, Chapter 490 &ndash; Page No 10062-10065</span></strong></span></span></p>",
      "correct_choice_id": 65735,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16458,
      "choices": [
        {
          "id": 65792,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Von Gierke&rsquo;s disease</span></span></span></p>"
        },
        {
          "id": 65793,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anderson&rsquo;s disease</span></span></span></p>"
        },
        {
          "id": 65794,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cori&rsquo;s disease</span></span></span></p>"
        },
        {
          "id": 65795,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pompe&rsquo;s disease</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old girl is brought in by her anxious mother due to a significantly enlarged abdomen and recurrent episodes of weakness, sweating, and pallor, which resolve after eating. The child has a history of delayed developmental milestones and poor academic performance. Physical examination reveals an enlarged, firm liver. Laboratory tests show hypoglycemia, acidosis (low pH), elevated lactate, triglycerides, ketones, and free fatty acids. A liver biopsy indicates high glycogen content with normal structure, and enzyme assays reveal markedly low levels of glucose-6-phosphatase. Based on these findings, what is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q7772640",
      "question_audio": null,
      "question_video": null,
      "map_id": 33050,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Von Gierke&rsquo;s disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Von Gierke&rsquo;s disease</strong>, also known as <strong>Glycogen Storage Disease Type Ia</strong>, is caused by a <strong>deficiency in the enzyme glucose-6-phosphatase</strong>, which is crucial for the <strong>final step of gluconeogenesis </strong>and <strong>glycogenolysis</strong>. This <strong>deficiency leads to the inability </strong>to <strong>convert glycogen into glucose</strong>, resulting in <strong>severe hypoglycemia</strong>, <strong>lactic acidosis</strong>, <strong>hyperlipidemia </strong>(elevated triglycerides and free fatty acids), and <strong>ketosis</strong>. The liver biopsy findings of high glycogen content with normal structure, alongside the clinical presentation of an enlarged liver, frequent hypoglycemic episodes, and the specific enzyme deficiency, strongly support the diagnosis of Von Gierke&rsquo;s disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Anderson&rsquo;s disease (Glycogen Storage Disease Type IV):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by <strong>abnormal glycogen </strong>with a <strong>branched structure</strong>, leading to <strong>liver cirrhosis</strong>, but not typically presenting with hypoglycemia or the specific metabolic abnormalities seen in Von Gierke&rsquo;s disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Cori&rsquo;s disease (Glycogen Storage Disease Type III):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Involves a <strong>deficiency in the debranching enzyme</strong>, leading to <strong>abnormal glycogen structure </strong>and <strong>mild hypoglycemia</strong>, but not as severe as in Von Gierke&rsquo;s disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pompe&rsquo;s disease (Glycogen Storage Disease Type II):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Caused by a <strong>deficiency in the lysosomal acid alpha-glucosidase</strong>, leading to <strong>glycogen accumulation in lysosomes</strong>, particularly affecting muscle tissue, not primarily associated with hypoglycemia or liver enlargement.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Von Gierke&rsquo;s disease </strong>(Glycogen Storage Disease Type Ia) through its hallmark features of <strong>hypoglycemia</strong>, <strong>lactic acidosis</strong>, <strong>hyperlipidemia</strong>, and <strong>hepatomegaly </strong>due to a <strong>deficiency in glucose-6-phosphatase</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affected <strong>tissue</strong>: Liver and kidney&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> large quantities of glycogen are formed and stored in hepatocytes, renal and intestinal mucosa cells<strong>. The liver and kidneys become enlarged. </strong>Abnormalities of <strong>lipids</strong> may lead to <strong>xanthoma formation. </strong>Uric acid is often elevated and may cause clinical gout. Galactose, fructose, and glycerol are metabolised to lactate. The elevated blood lactate levels cause metabolic acidosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Blood loss may require oral iron. Treatment of <strong>hyperuricaemia and pyelonephritis</strong> protect renal function. Diazoxide to maintain blood glucose has been disappointing. <strong>Liver transplantation</strong> for primary disease or for <strong>hepatocellular carcinoma</strong> seems effective.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelson 21<sup>st</sup> edition, Chapter 105 &ndash; Page No 3441-3446</span></strong></span></span></p>",
      "correct_choice_id": 65792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16464,
      "choices": [
        {
          "id": 65816,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkaptonuria and Autosomal Dominant.</span></span></span></p>"
        },
        {
          "id": 65817,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria and Autosomal Dominant.</span></span></span></p>"
        },
        {
          "id": 65818,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria and Autosomal Recessive</span></span></span></p>"
        },
        {
          "id": 65819,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkaptonuria and Autosomal Recessive</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Madhuri, an 11-year-old girl, presents with joint pain and stiffness, particularly in the hips and knees, and reports that her urine turns dark upon air exposure and has a peculiar odor. Physical examination shows pigmented areas on her skin, and laboratory tests reveal elevated levels of homogentisic acid in her urine. Based on these clinical findings, what is the most likely diagnosis and its mode of inheritance?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture6_o8HgSS1.jpg\" style=\"height:221px; width:300px\" />&nbsp; &nbsp; &nbsp;<img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture7_wX4aPp7.jpg\" style=\"height:324px; width:200px\" /></span></span></span></p>",
      "unique_key": "Q4075331",
      "question_audio": null,
      "question_video": null,
      "map_id": 33051,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Alkaptonuria and Autosomal Recessive</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkaptonuria is a rare <strong>autosomal recessive </strong>disorder caused by a deficiency in the enzyme <strong>homogentisate 1,2-dioxygenase</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features of <strong>Alkaptonuria:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Joint pain and stiffness, particularly affecting the spine and large joints</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dark pigmentation of the ears, sclera, and nails</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Development of small, bluish-black spots on the ears</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Difficulty breathing on exertion</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valvular heart disease</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal stones</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine turns dark upon exposure to air due to the accumulation of homogentisic acid in affected individuals</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated levels of homogentisic acid in blood tests due to the accumulation of homogentisic acid in connective tissues such as cartilage, tendons, and ligaments, leading to the formation of dark pigment known as &quot;ochronosis&quot;.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alkaptonuria and Autosomal Dominant:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is incorrect;<strong> alkaptonuria is autosomal recessive</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Phenylketonuria and Autosomal Dominant:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is incorrect; <strong>PKU is autosomal recessive </strong>and is not associated with joint pain or urine darkening.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Phenylketonuria and Autosomal Recessive:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Although <strong>PKU is autosomal recessive</strong>, it does<strong> not </strong>cause urine to <strong>darken or joint pain</strong>, making this option incorrect for the given clinical presentation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alkaptonuria </strong>is characterized by a deficiency in the enzyme <strong>homogentisate dioxygenase</strong>, leading to the accumulation of <strong>homogentisic acid</strong>, which can cause <strong>darkening of the urine upon exposure</strong> <strong>to air </strong>and <strong>joint pain </strong>due to <strong>ochronosis (buildup of homogentisic acid in connective tissues).&nbsp;</strong>The <strong>pigmentation </strong>found on physical examination further supports this diagnosis. Alkaptonuria is inherited in an<strong> autosomal recessive </strong>pattern.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelson 21<sup>st</sup> edition, Chapter 103 &ndash; Page No 3149-3150</span></strong></span></span></p>",
      "correct_choice_id": 65819,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16437,
      "choices": [
        {
          "id": 65708,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkaptonuria</span></span></span></p>"
        },
        {
          "id": 65709,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hartnup Disease </span></span></span></p>"
        },
        {
          "id": 65710,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria</span></span></span></p>"
        },
        {
          "id": 65711,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maple Syrup Urine Disease</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 9-month-old boy is brought to the pediatric emergency department due to multiple episodes of loose stools. The child appears dehydrated, with a dry mouth, but drinks water eagerly when offered. Following the administration of oral rehydration solution (ORS) according to protocol, further examination reveals photosensitivity and an ataxic gait. The mother reports a family history of two siblings with similar symptoms, though she and her husband are unaffected. Based on the clinical findings and family history, what is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture2_fXbtLrQ.jpg\" style=\"height:138px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q2201569",
      "question_audio": null,
      "question_video": null,
      "map_id": 33052,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Hartnup Disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hartnup Disease is a Autosomal Recessive disorder, </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">which has the clinical findings similar to Pellagra. The similarities like Dermatitis (photosensitive rash), diarrhoea and can lead to Dementia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Intestinal and renal tubular reabsorption defect of the <strong>neutral amino acids</strong> (alanine, valine, threonine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, histidine, glycine) <strong>Tryptophan deficiency</strong> leads to <strong>nicotinic acid and serotonin deficiency</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical finding:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Photodermatitis, cerebellar ataxia; often asymptomatic</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> High levels of neutral amino acids in urine low levels of neutral amino acids in plasma.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Nicotinamide, sun protection.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Alkaptonuria </strong>results from the <strong>deficiency of Homogentisate oxidase </strong>and has a clinical feature of changing of urine colour and Ochronosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Phenylketonuria results from the deficiency of phenylalanine hydroxylase and has clinical features of blond hair and skin changes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Maple Syrup Urine Disease has a clinical feature of burnt sugar smell of urine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hartnup disease, an autosomal recessive disorder characterized by diarrhea, dehydration, photosensitivity, and neurological symptoms such as ataxia. The family history of similarly affected siblings with unaffected parents supports the autosomal recessive inheritance pattern.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nelson 21<sup>st</sup> edition, Chapter 103 &ndash; Page No 3178</span></strong></span></span></p>",
      "correct_choice_id": 65709,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16456,
      "choices": [
        {
          "id": 65784,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osteodystrophy</span></span></span></p>"
        },
        {
          "id": 65785,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythrodontia</span></span></span></p>"
        },
        {
          "id": 65786,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clear Cornea</span></span></span></p>"
        },
        {
          "id": 65787,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutilation and Disfigurement</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old child is brought in by their mother due to a recurrent rash upon sun exposure and the passage of purple-colored urine. Following an examination, the child is diagnosed with Congenital Erythropoietic Porphyria, a disorder of heme biosynthesis. Which of the following is NOT a feature of Congenital Erythropoietic Porphyria? </span></span></span></p>",
      "unique_key": "Q1431401",
      "question_audio": null,
      "question_video": null,
      "map_id": 33049,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Clear Cornea </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital Erythropoietic Porphyria (CEP) is characterized by the accumulation of porphyrins leading to skin sensitivity to sunlight, resulting in blisters, erosion, and scarring of the skin. Erythrodontia (red-stained teeth under UV light) and mutilation and disfigurement due to skin damage are well-documented features. Osteodystrophy, which involves bone abnormalities, can also occur due to the accumulation of porphyrins in bone tissue.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The cornea typically remains unaffected directly by the porphyrins, which accumulate in various tissues due to CEP. However, secondary complications from severe facial and eyelid damage can potentially affect the eyes. Therefore, &quot;Clear Cornea&quot; is the correct choice as it is not a direct feature of CEP.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Osteodystrophy:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone abnormalities can occur in CEP due to porphyrin accumulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Erythrodontia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This refers to reddish-brown discoloration of the teeth, a hallmark sign of CEP, caused by the deposition of porphyrins in dental tissues.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Mutilation and Disfigurement:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe skin damage from photosensitivity reactions can lead to significant mutilation and disfigurement in CEP.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital erythropoietic porphyria</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enzyme defect: Uroporphyrinogen III cosynthase. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characteristic features</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - It is a rare congenital disorder. Mostly contained in erythropoietic tissues (bone). Clinical features include;</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe cutaneous photosensitivity with blistering and increased friability of the skin over light-exposed areas.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The first manifestation is often <strong>pink-to-dark red discoloration of the urine.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyrin deposition may lead to corneal ulcers and scarring,</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;reddish-brown discoloration of the teeth (erythrodontia), and </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone loss and/or expansion of the bone marrow.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutilation and Disfigurement.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>diagnosis</strong> of CEP in a proband with suggestive <strong>clinical and biochemical findings</strong> is most commonly established by identification of biallelic pathogenic variants in<strong> UROS.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of manifestations: There is no specific treatment for the photosensitivity. Currently, the only effective management is prevention of blistering by avoidance <strong>of sun and light exposure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Nelson 21<sup>st</sup> edition, Chapter 110 &ndash; Page No 3656-3662</span></strong></span></span></p>",
      "correct_choice_id": 65786,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16482,
      "choices": [
        {
          "id": 65888,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinemia type 1</span></span></span></p>"
        },
        {
          "id": 65889,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinemia type 2</span></span></span></p>"
        },
        {
          "id": 65890,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinemia type 3</span></span></span></p>"
        },
        {
          "id": 65891,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinemia type 4</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-month-old infant is brought to a pediatric outpatient department by his mother, who is concerned about her child&#39;s eyes, which have been showing excessive tearing, redness, and sensitivity to light for the past few weeks. She also mentions that her baby seems to be in pain when touching his feet. On examination, the pediatrician observes nonpruritic hyperkeratotic plaques on the soles of the infant&#39;s feet, a finding that is unusual and concerning. Laboratory investigations reveal elevated levels of tyrosine in the blood (hypertyrosinemia) and increased 4-hydroxyphenylpyruvic acid in the urine. Given these clinical features and laboratory findings, what is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q2235872",
      "question_audio": null,
      "question_video": null,
      "map_id": 33048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tyrosinemia type 2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyrosinemia type 2 </strong>(A/K/A <strong>richner hanhart syndrome/oculocutaneous tyrosinemia</strong>)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ocular manifestation: excessive tearing, redness, pain and photophobia.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skin manifestation: painful, nonpruritic hyperkeratotic plaques on soles and palms (seen in adults).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertyrosinemia(20-50mg/dl)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated 4 hydroxyphenylpyruvic acid in urine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated<strong> 4 hydroxyphenylpyruvic acid </strong>in urine has a significance in diagnosis of<strong> Tyrosinemia type 2</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Tyrosinemia type 1 </strong>is characterized by <strong>liver and kidney dysfunction, neurological crises, and a cabbage-like odor</strong>, but not typically by the skin and ocular findings seen in Tyrosinemia type II.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Tyrosinemia type 3 </strong>is very rare and typically presents with <strong>neurological symptoms</strong>; the characteristic skin and ocular features of Tyrosinemia type II are absent.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Tyrosinemia type 4 </strong>is <strong>not a recognized classification </strong>within the medical community for tyrosinemia, making it an incorrect option.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyrosinemia type II (Richner-Hanhart syndrome) </strong>is an <strong>autosomal recessive </strong>disorder caused by <strong>tyrosine aminotransferase deficiency</strong>, leading to <strong>elevated tyrosine and 4-hydroxyphenylpyruvic acid levels</strong>.<strong> Tyrosinemia type I </strong>involves <strong>liver and renal issues</strong>, while <strong>type III </strong>is associated <strong>with neurological symptoms</strong>, distinguishing them from type II. Tyrosinemia <strong>type IV is not recognized</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelson 21<sup>st</sup> Edition, Chapter 103 &ndash; Page No 3143 -3153</span></strong></span></span></p>",
      "correct_choice_id": 65889,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16480,
      "choices": [
        {
          "id": 65880,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkaptonuria and ferric chloride urine test</span></span></span></p>"
        },
        {
          "id": 65881,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkaptonuria and Agno3 test</span></span></span></p>"
        },
        {
          "id": 65882,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria and ferric chloride urine test</span></span></span></p>"
        },
        {
          "id": 65883,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria and Agno3 test</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A worried mother rushes her 1-year-old son to the emergency department of a district hospital in India, reporting that her child has just experienced a convulsive episode. She mentions that the child was healthy at birth and reached early developmental milestones on time, but she has been increasingly concerned about his slow growth and a persistent rash that she describes as similar to eczema. Upon examination, the emergency physician notes the distinctive eczematous rash and also detects a &quot;mousy&quot; odor in the child&#39;s urine, raising suspicion for a metabolic disorder. Given the combination of developmental concerns, seizure, eczematoid rash, and characteristic urine odor, which condition is most likely, and how should the diagnosis be confirmed?</span></span></span></p>",
      "unique_key": "Q4372611",
      "question_audio": null,
      "question_video": null,
      "map_id": 33047,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Phenylketonuria and ferric chloride urine test</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Classic Phenylketonuria-it is due to defect in<strong> phenylalaninie hydroxylase (PAH).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal at birth, intellectual <strong>disability develops gradually </strong>if infant remains<strong> untreated</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CLINICAL FEATURES-</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lighter in complexion (compared to their siblings)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seborrheic or eczematoid rash.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Musty or mousy ordor</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NEUROLOGOCAL signs: seizures, spasticity, hyperreflexia and tremors</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maxillae with widely spaced teeth and growth retardation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DIAGNOSIS-</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guthries test</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ferric chloride urine test</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased Blood phenylalanine(normal:2-6mg/dl)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alkaptonuria</strong> <strong>(Options A and B) </strong>is a different metabolic disorder characterized by the <strong>accumulation of homogentisic acid</strong>, leading to <strong>darkening of the urine upon standing and ochronosis </strong>(bluish-black discoloration of connective tissue), but it does not present with the clinical features described in the question, such as eczematoid rash and mousy odor urine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phenylketonuria</strong>, a treatable <strong>metabolic disorder</strong>, and the simple diagnostic tests like the <strong>ferric chloride urine test </strong>is used in <strong>initial screening</strong>, particularly in areas where more sophisticated <strong>diagnostic facilities may not be readily available</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelson 21<sup>st</sup> edition, Chapter 103 &ndash; Page No 3178</span></strong></span></span></p>",
      "correct_choice_id": 65882,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}